Natura Hue Chem (531834)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• P/B of 0.27 means shares trade at a 73% discount to stated book value of ₹26.43.
• Book value per share is more than 3.6x the current market price of ₹7.21.
• Market cap of ₹3 Cr is tiny and likely under-followed, creating potential pricing inefficiency.
• No operating earnings are being paid for — the market is pricing only the asset base, if anything.

Concerns

• Latest quarter sales are ₹0 Cr with a net loss; the business is not generating revenue.
• ROE of -0.73% and ROCE of -0.18% show capital is being eroded, not compounded.
• Piotroski F-Score of 2/9 signals very weak financial health and possible distress.
• Sales growth of 0.00% and profit growth of -50.00% show no credible path to growth.

AI Analysis

This is not a business I can love; it is, at best, a bag of assets. Natura Hue Chem trades at ₹7.21, while the books say equity is worth ₹26.43 per share. That is a price-to-book of 0.27 — a 73% discount. Graham would call that a margin of safety, but only if the book value is real and the capital is productive. Here, the latest quarter shows sales of ₹0 crore and a net loss, however small. Full-year numbers confirm the rot: ROE is -0.73% and ROCE is -0.18%, so the assets are not earning their keep; they are slowly bleeding. Profit growth is down 50%, and with zero sales growth, there is no engine for compounding. The Piotroski F-Score of 2 out of 9 is a red flag — this is not a financially healthy company. The FairStock Score is N/A due to insufficient data, which itself tells me to be cautious. In Buffett's language, a great business combines a durable moat with high returns on capital. Natura Hue Chem has no visible moat, no revenue, no earnings, and no dividend. The only attraction is the gap between price and stated book value. But unless management can sell assets, restart operations, or receive a bid, a discount to book can easily become a value trap. With a market cap of just ₹3 crore, it is also too small for institutional investors; only a specialist willing to do deep forensic work should touch it. I would not classify this as a growth story — it is a potential asset play, and the burden of proof is entirely on the numbers. I would wait for evidence that book value is not evaporating and that there is a credible path to turn assets into cash or earnings.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer